MAPT and Alzheimer disease: In this study, we have evaluated whether CBD pre-treatment in GMSCs modulated the transcription of genes involved in Aβ and tau generation, in order to understand whether CBD may confer to GMSCs a molecular profile with better therapeutic potential for the treatment of in vivo AD models compared to CTR-GMSCs.